Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development (net of collaboration funding of $600,072 and $1,648,631 in the three months ended June 30, 2023 and 2022, respectively, and of $1,318,482 and $4,648,002 in the six months ended June 30, 2023 and 2022, respectively)	$ 1,440,717	$ 3,426,773	$ 3,861,837	$ 6,598,412
General and administrative (net of collaboration funding of $1,404,695 and $3,257,701 in the three months ended June 30, 2023 and 2022, respectively, and of $2,547,291 and $5,629,876 in the six months ended June 30, 2023 and 2022, respectively)	2,853,760	3,638,073	5,421,942	7,513,674
Total operating expenses	4,294,477	7,064,846	9,283,779	14,112,086
Loss from operations	(4,294,477)	(7,064,846)	(9,283,779)	(14,112,086)
Other income (expense), net:
Costs of debt issuance		(200,129)	(577,225)	(1,368,194)
Loss on extinguishment of debt	(350,000)		(8,541,494)
Changes in fair value of debt instruments (loss) gain	(2,806,538)	4,729,460	(5,018,223)	3,767,060
Interest and other income (expense), net	(639,610)	(139,234)	(926,147)	(142,072)
Foreign currency transaction (loss) gain	(95)	7,713	(24,558)	9,252
Total other income (expense), net	(3,796,243)	4,397,810	(15,087,647)	2,266,046
Net loss	$ (8,090,720)	$ (2,667,036)	$ (24,371,426)	$ (11,846,040)
Net loss per share - basic	$ (0.33)	$ (0.17)	$ (1.07)	$ (0.80)
Weighted average common shares outstanding - basic	24,462,895	15,273,707	22,765,268	14,794,637
Net loss per share - diluted	$ (0.33)	$ (0.30)	$ (1.07)	$ (0.83)
Weighted average common shares outstanding - diluted	24,462,895	17,681,400	22,765,268	16,372,537